首页> 外文期刊>Stroke: A Journal of Cerebral Circulation >Path From Clinical Research to Implementation Endovascular Treatment of Ischemic Stroke in the Netherlands
【24h】

Path From Clinical Research to Implementation Endovascular Treatment of Ischemic Stroke in the Netherlands

机译:从临床研究中实现血管脑卒中血管脑卒中的途径

获取原文
获取原文并翻译 | 示例
       

摘要

Before 2015, endovascular treatment (EVT) for acute ischemic stroke was considered a promising treatment option. Based on limited evidence, it was performed in several dedicated stroke centers worldwide on selected patients. Since 2015, EVT for patients with intracranial large vessel occlusion has quickly been implemented as standard treatment in many countries worldwide, supported by the revised international guidelines based on solid evidence from multiple clinical trials. We describe the development in use of EVT in the Netherlands before, during, and after the pivotal EVT trials. We used data from all patients who were treated with EVT in the Netherlands from January 2002 until December 2018. We undertook a time-series analysis to examine trends in the use of EVT using Poisson regression analysis. Incidence rate ratios per year with 95% CIs were obtained to demonstrate the impact and implementation after the publication of the EVT trial results. We made regional observation plots, adjusted for stroke incidence, to assess the availability and use of the treatment in the country. In the buildup to the MR CLEAN (Multicenter Clinical Trial of Endovascular Treatment of Acute Ischemic Stroke in the Netherlands), a slow increase of EVT patients was observed, with 0.2% of all ischemic stroke patients receiving EVT. Before the trial results were formally announced, a statistically significant increase in EVT-treated patients per year was observed (incidence rate ratio, 1.72 [95% CI, 1.46-2.04]), and after the trial publication, an immediate steep increase was seen, followed by a more gradual increase (incidence rate ratio, 2.14 [95% CI, 1.77-2.59]). In 2018, the percentage of ischemic stroke patients receiving EVT increased to 5.8%. A well-developed infrastructure, a pragmatic approach toward the use of EVT in clinical practice, in combination with a strict adherence by the regulatory authorities to national evidence-based guidelines has led to successful implementation of EVT in the Netherlands. Ongoing efforts are directed at further increasing the proportion of stroke patients with EVT in all regions of the country.
机译:在2015年之前,急性缺血中风的血管内治疗(EVT)被认为是一个有前途的治疗选择。根据有限的证据,它是在全球各地的患者的几个专用中风中心进行。自2015年以来,为颅内大血管闭塞患者EVT在全球许多国家的标准治疗中迅速实施,该指南根据来自多种临床试验的固体证据得到了修订的国际指南。我们描述了在荷兰之前,期间和在枢轴EVT试验期间使用EVT的发展。我们从2002年1月到2018年12月在荷兰在荷兰治疗的所有患者中使用了数据。我们进行了一系列时间序列分析,审查使用泊松回归分析使用EVT的趋势。获得95%CIS的每年发生率比率,以证明eVT试验结果出版后的影响和实施。我们制造了区域观察情节,调整了冲程入射,评估了该国治疗的可用性和使用。在累积到清洁先生(荷兰急性缺血性脑卒中血管内治疗的多中心临床试验)中,观察到evt患者的缓慢增加,患有EVT的所有缺血性卒中患者的0.2%。在正式宣布试验之前,观察到每年患有患者的统计学上显着增加(发病率比,1.72 [95%CI,1.46-2.04]),并在试验后,看到了立即陡峭的增加,然后更加逐渐增加(发病率比,2.14 [95%CI,1.77-2.59])。 2018年,接受EVT的缺血性卒中患者的百分比增加至5.8%。一个发达的基础设施,临床实践中使用EVT的务实方法,以及监管机构对国家基于证据的指导方针的严格遵守,导致荷兰的EVT成功实施。正在进行的努力,进一步增加了在国家所有地区的脑卒中患者的比例。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号